"recurrent cancer" trang 2 - tải miễn phí từ tailieuXANH
Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas

Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas
10    49    0
Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients

Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients
11    64    0
Advantages of intensity modulated radiotherapy in recurrent T1-2 nasopharyngeal carcinoma: A retrospective study

Advantages of intensity modulated radiotherapy in recurrent T1-2 nasopharyngeal carcinoma: A retrospective study
8    53    0
The combination of 13N-ammonia and 11C-methionine in differentiation of residual/ recurrent pituitary adenoma from the pituitary gland remnant after trans-sphenoidal Adenomectomy

The combination of 13N-ammonia and 11C-methionine in differentiation of residual/ recurrent pituitary adenoma from the pituitary gland remnant after trans-sphenoidal Adenomectomy
7    21    1
Online calculator to predict early mortality in patient with surgically treated recurrent lower-grade glioma

Online calculator to predict early mortality in patient with surgically treated recurrent lower-grade glioma
10    8    1
BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: A first-inhuman phase-I study

BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: A first-inhuman phase-I study
8    56    0
Efficacy and safety of target combined chemotherapy in advanced gastric cancer: A meta-analysis and system review

Efficacy and safety of target combined chemotherapy in advanced gastric cancer: A meta-analysis and system review
9    70    0
Multicenter phase II study of FOLFIRI plus bevacizumab after discontinuation of oxaliplatin-based regimen for advanced or recurrent colorectal cancer (CR0802)

Multicenter phase II study of FOLFIRI plus bevacizumab after discontinuation of oxaliplatin-based regimen for advanced or recurrent colorectal cancer (CR0802)
8    46    0
Salvage cytoreductive surgery for patients with recurrent endometrial cancer: A retrospective study

Salvage cytoreductive surgery for patients with recurrent endometrial cancer: A retrospective study
8    54    0
Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: A single-center real-world data

Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: A single-center real-world data
8    34    1
Randomized phase II study of SOX+B-mab versus SOX+C-mab in patients with previously untreated recurrent advanced colorectal cancer with wild-type KRAS (MCSGO-1107 study)

Randomized phase II study of SOX+B-mab versus SOX+C-mab in patients with previously untreated recurrent advanced colorectal cancer with wild-type KRAS (MCSGO-1107 study)
10    41    1
Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer

Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer
10    59    0
Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy

Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
9    53    0
Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer

Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer
12    53    0
Hereditary breast and ovarian cancer in Andalusian families: A genetic population study

Hereditary breast and ovarian cancer in Andalusian families: A genetic population study
12    72    0
Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer

Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer
9    76    0
Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/ recurrent gastric cancer previously untreated with chemotherapy

Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/ recurrent gastric cancer previously untreated with chemotherapy
7    77    0
A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites

A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites
7    98    0
Identification of novel enriched recurrent chimeric COL7A1-UCN2 in human laryngeal cancer samples using deep sequencing

Identification of novel enriched recurrent chimeric COL7A1-UCN2 in human laryngeal cancer samples using deep sequencing
12    41    0
High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy

High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy
9    63    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.